Actinic Keratoses Agents

Actinic keratoses agents represent a functional therapeutic category of topical dermatologic medications and photosensitizers used primarily to treat actinic keratoses—precancerous skin lesions caused by chronic ultraviolet radiation exposure Their central therapeutic role is to clear dysplastic epidermal lesions and reduce the long-term risk of malignant progression to cutaneous squamous cell carcinoma

Actinic keratoses agents represent a functional therapeutic category of topical dermatologic medications and photosensitizers used primarily to treat actinic keratoses—precancerous skin lesions caused by chronic ultraviolet radiation exposure

Rather than sharing a single chemical class, these agents work through diverse pharmacologic mechanisms, including antimetabolite inhibition of cellular proliferation, immune response modification, microtubule disruption, cyclooxygenase inhibition, and light-activated generation of cytotoxic reactive oxygen species

Rather than sharing a single chemical class, these agents work through diverse pharmacologic mechanisms, including antimetabolite inhibition of cellular proliferation, immune response modification, microtubule disruption, cyclooxygenase inhibition, and light-activated generation of cytotoxic reactive oxygen species Their central therapeutic role is to clear dysplastic epidermal lesions and reduce the long-term risk of malignant progression to cutaneous squamous cell carcinoma

Rather than sharing a single chemical class, these agents work through diverse pharmacologic mechanisms, including antimetabolite inhibition of cellular proliferation, immune response modification, microtubule disruption, cyclooxygenase inhibition, and light-activated generation of cytotoxic reactive oxygen species

Rather than sharing a single chemical class, these agents work through diverse pharmacologic mechanisms, including antimetabolite inhibition of cellular proliferation, immune response modification, microtubule disruption, cyclooxygenase inhibition, and light-activated generation of cytotoxic reactive oxygen species Select agents within this grouping are also approved for related dermatologic malignancies, such as superficial basal cell carcinoma